Loading clinical trials...

3D Designed Defocus Lenses on Myopia Control in Children and Adolescents | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATIONNA

3D Designed Defocus Lenses on Myopia Control in Children and Adolescents

Clinical Study on the Control Effect of 3D Designed Defocus Lenses on Myopia in Children and Adolescents

NCT07284147•Shanghai Eye Disease Prevention and Treatment Center

Summary

This study aims to evaluate the effectiveness of lenses with 3D Designed Defocus in controlling the progression of myopia in children and adolescents, and to explore the feasibility of effective design, and apply personalized frame lenses for myopia prevention and control.

Eligibility

Age

6 - 14 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age: 6-14 years old; After using 1% cyclohexanone hydrochloride eye drops (Saifeijie) for ciliary muscle paralysis, binocular spherical power were within -0.40D\~-4.00D, binocular cylinder power ≤ 1.50D, the anisometropia is ≤ 1.50D, the progression of myopia in the past year is greater than 0.5D, the best corrected far vision is at least 4.8, and the near vision is at least 5.0; Within 3 months, the myopia prevention and control methods such as multifocal glasses, orthokeratology, defocusing flexible glasses, progressive glasses, atropine eye drops, red light and acupuncture and moxibustion treatment were not used; The subject has a willingness to receive treatment and an informed consent form is signed by their legal guardian.

Exclusion Criteria

•\-

Locations (1)

Shanghai Eye Diseases Prevention &Treatment Center/ Shanghai Eye Hospital, School of Medicine, Tongji University

Shanghai, China

Key Dates

Start Date

September 1, 2025

Primary Completion Date

February 1, 2026

Completion Date

August 31, 2027

Last Updated

December 16, 2025

Enrollment

144

ESTIMATED participants

Conditions

Myopia Progressing

Interventions

Defocus Lenses

DEVICE

Brain Visual Perception Training for Prevention and Control of Premyopia

NCT06585657

Visual FunctionMyopia Progressing

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 16, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions